HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 183 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6 | +500.0% | 193 | +451.4% | 0.00% | – |
Q2 2023 | $1 | -100.0% | 35 | -62.4% | 0.00% | – |
Q1 2022 | $5,000 | +25.0% | 93 | 0.0% | 0.00% | – |
Q4 2021 | $4,000 | 0.0% | 93 | 0.0% | 0.00% | – |
Q3 2021 | $4,000 | +33.3% | 93 | 0.0% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 93 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | – | 93 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $394,762,581 | 98.29% |
venBio Partners LLC | 1,035,396 | $36,435,585 | 13.19% |
Nan Fung Group Holdings Ltd | 368,665 | $12,973,321 | 8.29% |
Vivo Capital, LLC | 2,606,247 | $91,713,832 | 6.33% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $20,070,190 | 6.11% |
Altium Capital Management LP | 149,889 | $5,274,594 | 3.99% |
AlphaCentric Advisors LLC | 118,000 | $4,152,420 | 2.30% |
ASHFORD CAPITAL MANAGEMENT INC | 449,038 | $15,801,647 | 2.21% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,240 | $22,389,286 | 2.05% |
TANG CAPITAL MANAGEMENT LLC | 271,200 | $9,543,528 | 1.40% |